Michael Forbes, CEO of Adastra, stated in his First press release: “Hurt reduction is often a critically vital and mainstream subject, and we are keeping on the forefront of drug polices over the board.”"However you might have a non-consumer who would like to experiment appear in this article and get it done," he clarified, adding that he would